Oatmeal Health Launches AI Lung Cancer Screening for Underserved FQHCs

Oatmeal Health, a leader in AI-driven cancer screening, has launched its AI-powered radiology risk stratification platform for lung cancer. Designed to improve accessibility and affordability, the solution serves as a fully reimbursable second-opinion diagnostic tool covered by Medicare.

Lung cancer remains one of the deadliest cancers worldwide, yet screening rates are critically low. Oatmeal Health’s platform aims to change this by leveraging AI to enhance the accuracy and efficiency of lung cancer detection, particularly in underserved communities. Using advanced AI and computer vision, the platform analyzes 3D low-dose CT scans to automatically detect, assess, and categorize lung nodules based on risk. This technology streamlines workflows, reduces diagnostic errors, and provides healthcare providers with actionable insights for timely interventions.

The platform follows a structured process: it ingests CT scan data, identifies regions of interest, and encodes nodule- and scan-level features. The data is then processed through a proprietary deep learning framework with convolutional neural networks (CNNs) optimized for 3D imaging. Its risk stratification capabilities, powered by advanced computer-aided detection (CADe) and diagnosis (CADx) methodologies, align with established protocols like Lung-RADS. Trained on a diverse dataset of over 100,000 CT scans, the platform demonstrates exceptional accuracy, with an AUROC of 0.94, reinforcing its reliability in clinical settings.

In pilot programs, Oatmeal Health’s platform has already shown significant impact, achieving a 90% patient conversion rate for telemedicine-based shared decision-making visits. The company continues to collaborate with healthcare providers, payers, and policymakers to drive AI adoption and improve lung cancer outcomes.

“Our mission is clear: to democratize access to life-saving cancer screening technologies, particularly in communities that need it most,” said Jonathan Govette, CEO of Oatmeal Health. “By leveraging AI and focusing on underserved populations, we’re not just improving screening rates—we’re saving lives and setting a new standard for equitable healthcare.”